DelveInsight's Emphysema Market Insights report includes a comprehensive understanding of current treatment practices, ...
Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback